263 related articles for article (PubMed ID: 33767059)
41. APOL1 C-Terminal Variants May Trigger Kidney Disease through Interference with APOL3 Control of Actomyosin.
Uzureau S; Lecordier L; Uzureau P; Hennig D; Graversen JH; Homblé F; Mfutu PE; Oliveira Arcolino F; Ramos AR; La Rovere RM; Luyten T; Vermeersch M; Tebabi P; Dieu M; Cuypers B; Deborggraeve S; Rabant M; Legendre C; Moestrup SK; Levtchenko E; Bultynck G; Erneux C; Pérez-Morga D; Pays E
Cell Rep; 2020 Mar; 30(11):3821-3836.e13. PubMed ID: 32187552
[TBL] [Abstract][Full Text] [Related]
42. Variant APOL1 protein in plasma associates with larger particles in humans and mouse models of kidney injury.
Andrews M; Yoshida T; Henderson CM; Pflaum H; McGregor A; Lieberman JA; de Boer IH; Vaisar T; Himmelfarb J; Kestenbaum B; Chung JY; Hewitt SM; Santo BA; Ginley B; Sarder P; Rosenberg AZ; Murakami T; Kopp JB; Kuklenyik Z; Hoofnagle AN
PLoS One; 2022; 17(10):e0276649. PubMed ID: 36279295
[TBL] [Abstract][Full Text] [Related]
43. APOL1 risk variants in kidney transplantation: a modulation of immune cell function.
Malone AF
J Clin Invest; 2021 Nov; 131(22):. PubMed ID: 34779415
[TBL] [Abstract][Full Text] [Related]
44. Kidney-disease-associated variants of Apolipoprotein L1 show gain of function in cation channel activity.
Bruno J; Edwards JC
J Biol Chem; 2021; 296():100238. PubMed ID: 33380423
[TBL] [Abstract][Full Text] [Related]
45. APOL1: The Balance Imposed by Infection, Selection, and Kidney Disease.
Beckerman P; Susztak K
Trends Mol Med; 2018 Aug; 24(8):682-695. PubMed ID: 29886044
[TBL] [Abstract][Full Text] [Related]
46. APOL1 Kidney Disease Risk Variants: An Evolving Landscape.
Dummer PD; Limou S; Rosenberg AZ; Heymann J; Nelson G; Winkler CA; Kopp JB
Semin Nephrol; 2015 May; 35(3):222-36. PubMed ID: 26215860
[TBL] [Abstract][Full Text] [Related]
47. Impact of APOL1 polymorphism and IL-1β priming in the entry and persistence of HIV-1 in human podocytes.
Mikulak J; Oriolo F; Portale F; Tentorio P; Lan X; Saleem MA; Skorecki K; Singhal PC; Mavilio D
Retrovirology; 2016 Sep; 13(1):63. PubMed ID: 27599995
[TBL] [Abstract][Full Text] [Related]
48. APOL1 nephropathy: from gene to mechanisms of kidney injury.
Kruzel-Davila E; Wasser WG; Aviram S; Skorecki K
Nephrol Dial Transplant; 2016 Mar; 31(3):349-58. PubMed ID: 25561578
[TBL] [Abstract][Full Text] [Related]
49. Apolipoprotein L1 (APOL1) Coding Variants Are Associated With Creatinine Rise After Cardiac Surgery.
Privratsky JR; Li YJ; Haynes C; Podgoreanu M; Mathew J; Shah SH; Stafford-Smith M
J Cardiothorac Vasc Anesth; 2020 Dec; 34(12):3314-3320. PubMed ID: 32434723
[TBL] [Abstract][Full Text] [Related]
50. APOL1 and kidney cell function.
Kumar V; Singhal PC
Am J Physiol Renal Physiol; 2019 Aug; 317(2):F463-F477. PubMed ID: 31241995
[TBL] [Abstract][Full Text] [Related]
51. Apolipoprotein L1 nephropathies: 2017 in review.
Kopp JB; Roshanravan H; Okamoto K
Curr Opin Nephrol Hypertens; 2018 May; 27(3):153-158. PubMed ID: 29389775
[TBL] [Abstract][Full Text] [Related]
52. COVID-19-Associated Glomerular Disease.
Shetty AA; Tawhari I; Safar-Boueri L; Seif N; Alahmadi A; Gargiulo R; Aggarwal V; Usman I; Kisselev S; Gharavi AG; Kanwar Y; Quaggin SE
J Am Soc Nephrol; 2021 Jan; 32(1):33-40. PubMed ID: 33214201
[TBL] [Abstract][Full Text] [Related]
53.
Cooper A; Ilboudo H; Alibu VP; Ravel S; Enyaru J; Weir W; Noyes H; Capewell P; Camara M; Milet J; Jamonneau V; Camara O; Matovu E; Bucheton B; MacLeod A
Elife; 2017 May; 6():. PubMed ID: 28537557
[TBL] [Abstract][Full Text] [Related]
54. Copy Number Variation at the APOL1 Locus.
Ruchi R; Genovese G; Lee J; Charoonratana VT; Bernhardy AJ; Alper SL; Kopp JB; Thadhani R; Friedman DJ; Pollak MR
PLoS One; 2015; 10(5):e0125410. PubMed ID: 25933006
[TBL] [Abstract][Full Text] [Related]
55. Distinct APOL1 functions in trypanosomes and kidney podocytes.
Pays E
Trends Parasitol; 2022 Feb; 38(2):104-108. PubMed ID: 34887168
[TBL] [Abstract][Full Text] [Related]
56. The evolving story of apolipoprotein L1 nephropathy: the end of the beginning.
Daneshpajouhnejad P; Kopp JB; Winkler CA; Rosenberg AZ
Nat Rev Nephrol; 2022 May; 18(5):307-320. PubMed ID: 35217848
[TBL] [Abstract][Full Text] [Related]
57. APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans.
Gutiérrez OM; Judd SE; Irvin MR; Zhi D; Limdi N; Palmer ND; Rich SS; Sale MM; Freedman BI
Nephrol Dial Transplant; 2016 Apr; 31(4):602-8. PubMed ID: 26152403
[TBL] [Abstract][Full Text] [Related]
58. The Mechanism of Kidney Disease Due to APOL1 Risk Variants.
Pays E
J Am Soc Nephrol; 2020 Nov; 31(11):2502-2505. PubMed ID: 32943491
[No Abstract] [Full Text] [Related]
59. APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease.
Bruggeman LA; Wu Z; Luo L; Madhavan SM; Konieczkowski M; Drawz PE; Thomas DB; Barisoni L; Sedor JR; O'Toole JF
J Am Soc Nephrol; 2016 Dec; 27(12):3600-3610. PubMed ID: 27026370
[TBL] [Abstract][Full Text] [Related]
60. Mechanisms of Injury in APOL1-associated Kidney Disease.
Ma L; Divers J; Freedman BI
Transplantation; 2019 Mar; 103(3):487-492. PubMed ID: 30371607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
